Insider transactions

EDGAR

LAKE SHORE BANCORP, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
0 transactions, — shares

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–34 of 34

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-09-08 Filed 2026-09-09Sanvidge Kevin M. Director · Other: Chairman of the Board
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)14,56310.62
154,659.06

Derived: shares × price per share. Exact value 154659.06.

71,887Direct (D) No
F1, F2
  • F1 Exercise price amounted to $10.61392708, which represents the original exercise price of $14.38, updated for the 1.3549 to 1.00 exchange in connection with the Company's mutual to stock conversion, so that the aggregate cost of the options remained unchanged after conversion. This and previous filings present the exercise price rounded up to the nearest whole penny, or $10.62. No fractional shares were issued to the reporting person.
  • F2 Includes 893 shares of unvested restricted stock which vest on December 9, 2026, and 893 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-386509 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-09Sanvidge Kevin M. Director · Other: Chairman of the Board
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option (right to buy) — underlying Common Stock (14,563) — exercise price 10.62
Disposed (D)14,5630—0Direct (D) No
F1, F3
  • F1 Exercise price amounted to $10.61392708, which represents the original exercise price of $14.38, updated for the 1.3549 to 1.00 exchange in connection with the Company's mutual to stock conversion, so that the aggregate cost of the options remained unchanged after conversion. This and previous filings present the exercise price rounded up to the nearest whole penny, or $10.62. No fractional shares were issued to the reporting person.
  • F3 Options are fully vested.
Open filing 0001193125-26-386509 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25Werdein Jeffrey M. Officer: EVP-Commercial Division
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)23,13210.62
245,661.84

Derived: shares × price per share. Exact value 245661.84.

77,387Direct (D) No
F1
  • F1 Exercise price amounted to $10.61342469, which represents the original exercise price of $14.38, updated for the 1.3549 to 1.00 exchange in connection with the Company's mutual to stock conversion, so that the aggregate cost of the options remained unchanged after conversion. This and previous filings present the exercise price rounded up to the nearest whole penny, or $10.62. No fractional shares were issued to the reporting person.
Open filing 0001193125-26-365199 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25Werdein Jeffrey M. Officer: EVP-Commercial Division
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)16,52517.25
285,056.25

Derived: shares × price per share. Exact value 285056.25.

60,862Direct (D) No
F2, F3, F4, F5
  • F2 The number of shares reported as disposed of represents shares withheld by the issuer through net settlement to satisfy the exercise price of the option award and the tax liability incident to the withholding of shares. No shares were sold in the open market.
  • F3 Includes 3,025 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal installments beginning on the first anniversary of the grant.
  • F4 Includes 3,063 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F5 Includes 1,717 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
Open filing 0001193125-26-365199 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-25Werdein Jeffrey M. Officer: EVP-Commercial Division
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Option (right to buy) — underlying Common Stock (23,132) — exercise price 10.62
Disposed (D)23,1320—0Direct (D) No
F1, F8
  • F1 Exercise price amounted to $10.61342469, which represents the original exercise price of $14.38, updated for the 1.3549 to 1.00 exchange in connection with the Company's mutual to stock conversion, so that the aggregate cost of the options remained unchanged after conversion. This and previous filings present the exercise price rounded up to the nearest whole penny, or $10.62. No fractional shares were issued to the reporting person.
  • F8 Options are fully vested.
Open filing 0001193125-26-365199 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-04Brautigam Sharon E Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)1,0287.89
8,110.92

Derived: shares × price per share. Exact value 8110.92.

24,842Direct (D) No
F1
  • F1 Includes 893 shares of unvested restricted stock which vest on December 9, 2026, and 527 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-257509 Read from the filing’s XML Dispute this row
2026-06-04 Filed 2026-06-04Brautigam Sharon E Director
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (1,028) — exercise price 7.89
Disposed (D)1,0280—1,542Direct (D) No
F2
  • F2 Includes 1,542 remaining unvested options, post transaction, which were granted on April 23, 2024 and were scheduled to vest in five equal annual installments beginning on the first anniversary of the grant.
Open filing 0001193125-26-257509 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-24LIDDELL KIM C Other: Dir., Pres. and CEO of Bank
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)63115.85
10,001.35

Derived: shares × price per share. Exact value 10001.35.

70,367Direct (D) No
F1, F2, F3, F4
  • F1 The reporting person elected to pay for a tax liability by withholding securities incident to the vesting of a security (restricted stock) based on a market price of $15.85.
  • F2 Includes 6,363 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F3 Includes 3,499 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant. 1,748 shares vested on April 23, 2026.
  • F4 Includes 6,285 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal annual installments beginning on the first anniversary of the grant.
Open filing 0001193125-26-177482 Read from the filing’s XML Dispute this row
2026-04-23 Filed 2026-04-24Werdein Jeffrey M. Officer: EVP-Commercial Division
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)30215.85
4,786.7

Derived: shares × price per share. Exact value 4786.70.

54,255Direct (D) No
F1, F2, F3, F4
  • F1 The reporting person elected to pay for a tax liability by withholding securities incident to the vesting of a security (restricted stock) based on a market price of $15.85 per share.
  • F2 Includes 3,025 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal installments beginning on the first anniversary of the grant.
  • F3 Includes 3,063 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F4 Includes 1,717 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant. 858 shares vested on April 23, 2026.
Open filing 0001193125-26-177501 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Gilden Taylor M Officer: CFO and Treasurer
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,0280.00
0

Derived: shares × price per share. Exact value 0.00.

22,403Direct (D) No
F1, F2, F3, F4
  • F1 Shares of restricted stock vest in four equal annual installments beginning on March 18, 2027.
  • F2 Includes 2,788 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F3 Includes 4,245 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F4 Includes 3,028 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal annual installments beginning on the first anniversary of the grant.
Open filing 0001193125-26-117731 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Werdein Jeffrey M. Officer: EVP-Commercial Division
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,0250.00
0

Derived: shares × price per share. Exact value 0.00.

54,557Direct (D) No
F1, F2, F3, F4
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 3,025 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal annual installments beginning on the first anniversary of the grant.
  • F3 Includes 3,063 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F4 Includes 2,575 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
Open filing 0001193125-26-117727 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Passafaro Ronald J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5730.00
0

Derived: shares × price per share. Exact value 0.00.

45,837Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 573 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117733 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Segarra Ann M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6200.00
0

Derived: shares × price per share. Exact value 0.00.

6,692Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Include 5,058 shares of unvested restricted stock which vest on December 9, 2026, and 620 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117714 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20LIDDELL KIM C Other: Dir., Pres. and CEO of Bank
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6,2850.00
0

Derived: shares × price per share. Exact value 0.00.

70,998Direct (D) No
F1, F2, F3, F4
  • F1 Shares of restricted stock vest in four equal installments beginning on March 18, 2027.
  • F2 Includes 6,363 remaining shares of unvested restricted stock that were granted on March 12, 2025 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F3 Includes 5,247 remaining shares of unvested restricted stock that were granted on April 23, 2024 and were scheduled to vest in four equal annual installments beginning on the first anniversary of the grant.
  • F4 Includes 6,285 shares of unvested restricted stock that were granted on March 18, 2026 and vest in four equal annual installments beginning on the first anniversary of the grant.
Open filing 0001193125-26-117729 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20McGrath John P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5890.00
0

Derived: shares × price per share. Exact value 0.00.

10,873Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 589 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117718 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Brautigam Sharon E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5270.00
0

Derived: shares × price per share. Exact value 0.00.

23,814Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 893 shares of unvested restricted stock which vest on December 9, 2026, and 527 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117722 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Mehltretter John L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)6670.00
0

Derived: shares × price per share. Exact value 0.00.

19,600Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 667 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117723 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20Sanvidge Kevin M. Director · Other: Chairman of the Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8930.00
0

Derived: shares × price per share. Exact value 0.00.

57,324Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 893 shares of unvested restricted stock which vest on December 9, 2026, and 893 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117717 Read from the filing’s XML Dispute this row
2026-03-18 Filed 2026-03-20DeBergalis Michelle M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)4800.00
0

Derived: shares × price per share. Exact value 0.00.

8,859Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on March 18, 2027.
  • F2 Includes 3,868 shares of unvested restricted stock which vest on December 9, 2026, and 480 shares of unvested restricted stock which vest on March 18, 2027.
Open filing 0001193125-26-117715 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-13Werdein Jeffrey M. Officer: EVP-Commercial Division
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)36815.43
5,678.24

Derived: shares × price per share. Exact value 5678.24.

51,532Direct (D) No
F1, F2, F3
  • F1 The reporting person elected to pay for a tax liability by withholding securities incident to the vesting of a security (restricted stock) based on a market price of $15.43 per share.
  • F2 Includes 3,063 remaining shares of restricted stock that were granted on March 12, 2025 and vest in four equal annual installments beginning on the first anniversary of the grant. 1,021 shares vested on March 12, 2026.
  • F3 Includes 2,575 remaining shares of restricted stock that were granted on April 23, 2024 and vest in four equal annual installments beginning on the first anniversary of the grant. 858 shares vested on April 23, 2025.
Open filing 0001193125-26-106294 Read from the filing’s XML Dispute this row
2026-03-12 Filed 2026-03-13LIDDELL KIM C Other: Dir., Pres. and CEO of Bank
F

Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3

Common Stock
Disposed (D)76515.43
11,803.95

Derived: shares × price per share. Exact value 11803.95.

64,713Direct (D) No
F1, F2, F3
  • F1 The reporting person elected to pay for a tax liability by withholding securities incident to the vesting of a security (restricted stock) based on a market price of $15.43 per share.
  • F2 Includes 6,363 remaining shares of restricted stock that were granted on March 12, 2025 and vest in four equal annual installments beginning on the first anniversary of the grant. 2,121 shares vested on March 12, 2026.
  • F3 Includes 5,247 remaining shares of restricted stock that were granted on April 23, 2024 and vest in four equal annual installments beginning on the first anniversary of the grant. 1,748 shares vested on April 23, 2025.
Open filing 0001193125-26-106290 Read from the filing’s XML Dispute this row
2025-12-10 Filed 2026-01-23Sanvidge Kevin M. Director · Other: Chairman of the Board
G

Bona fide gift

Common Stock
Disposed (D)1,3820.00
0

Derived: shares × price per share. Exact value 0.00.

56,431Direct (D) No
F1
  • F1 Includes 1,415 shares of restricted stock which vest on March 12, 2026 and 893 shares of restricted stock which vest on December 9, 2026.
Open filing 0001193125-26-021143 Read from the filing’s XML Dispute this row
2025-12-10 Filed 2026-01-23Sanvidge Kevin M. Director · Other: Chairman of the Board
G

Bona fide gift

Common Stock
Acquired (A)1,3820.00
0

Derived: shares × price per share. Exact value 0.00.

3,150Indirect (I) As Custodian for GrandchildrenNo— Open filing 0001193125-26-021143 Read from the filing’s XML Dispute this row
2025-12-10 Filed 2025-12-11Sanvidge Kevin M. Director · Other: Chairman of the Board
G

Bona fide gift

Common Stock
Disposed (D)1,3820.00
0

Derived: shares × price per share. Exact value 0.00.

55,538Direct (D) No
F1
  • F1 Includes 1,415 shares of restricted stock which vest on March 12, 2026.
Open filing 0001193125-25-315969 Read from the filing’s XML Dispute this row
2025-12-10 Filed 2025-12-11Sanvidge Kevin M. Director · Other: Chairman of the Board
G

Bona fide gift

Common Stock
Acquired (A)1,3820.00
0

Derived: shares × price per share. Exact value 0.00.

3,150Indirect (I) As Custodian for GrandchildrenNo— Open filing 0001193125-25-315969 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23Passafaro Ronald J Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,749) — exercise price 14.85
Acquired (A)10,7490—10,749Direct (D) No
F2
  • F2 Stock options vest at a rate of 20% per year commencing on December 9, 2026.
Open filing 0001193125-26-021114 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23Sanvidge Kevin M. Director · Other: Chairman of the Board
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8930.00
0

Derived: shares × price per share. Exact value 0.00.

57,813Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on December 9, 2026.
  • F2 Includes 1,415 shares of restricted stock which vest on March 12, 2026 and 893 shares of restricted stock which vest on December 9, 2026.
Open filing 0001193125-26-021102 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23Mehltretter John L Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (5,237) — exercise price 14.85
Acquired (A)5,2370—5,237Direct (D) No
F2
  • F2 Stock options vest at a rate of 20% per year commencing on December 9, 2026.
Open filing 0001193125-26-021100 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23Brautigam Sharon E Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)8930.00
0

Derived: shares × price per share. Exact value 0.00.

23,287Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on December 9, 2026.
  • F2 Includes 815 shares of restricted stock which vest on March 12, 2026 and 893 shares of restricted stock which vest on December 9, 2026.
Open filing 0001193125-26-021111 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23DeBergalis Michelle M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)3,8680.00
0

Derived: shares × price per share. Exact value 0.00.

8,379Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on December 9, 2026.
  • F2 Includes 647 shares of restricted stock which vest on March 12, 2026 and 3,868 shares of restricted stock which vest on December 9, 2026.
Open filing 0001193125-26-021109 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23DeBergalis Michelle M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (8,220) — exercise price 14.85
Acquired (A)8,2200—8,220Direct (D) No
F3
  • F3 Stock options vest at a rate of 20% per year commencing on December 9, 2026.
Open filing 0001193125-26-021109 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23Segarra Ann M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Common Stock
Acquired (A)5,0580.00
0

Derived: shares × price per share. Exact value 0.00.

6,072Direct (D) No
F1, F2
  • F1 Shares of restricted stock vest on December 9, 2026.
  • F2 Includes 837 shares of restricted stock which vest on March 12, 2026 and 5,058 shares of restricted stock which vest on December 9, 2026.
Open filing 0001193125-26-021112 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23Segarra Ann M Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (10,749) — exercise price 14.85
Acquired (A)10,7490—10,749Direct (D) No
F3
  • F3 Stock options vest at a rate of 20% per year commencing on December 9, 2026.
Open filing 0001193125-26-021112 Read from the filing’s XML Dispute this row
2025-12-09 Filed 2026-01-23McGrath John P Director
A

Grant, award or other acquisition pursuant to Rule 16b-3(d)

Derivative security: Stock Option (Right to Buy) — underlying Common Stock (8,220) — exercise price 14.85
Acquired (A)8,2200—8,220Direct (D) No
F2
  • F2 Stock options vest at a rate of 20% per year commencing on December 9, 2026.
Open filing 0001193125-26-021101 Read from the filing’s XML Dispute this row

Latest reported holdings

What each reporting owner last said they hold, as of the date shown. A transaction not yet filed is not in it.

Latest reported holdings
Reporting ownerSecurityShares owned afterDirect or indirectSource
Brautigam Sharon E DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock2,570D As of 2026-03-20 Open filing 4
Brautigam Sharon E DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock1,542D As of 2026-06-04 Open filing 4
Brautigam Sharon E DirectorCommon Stock 22,394D As of 2025-07-18 Open filing 3
Brautigam Sharon E DirectorCommon Stock 20,000I By IRAAs of 2026-06-04 Open filing 4
Brautigam Sharon E DirectorCommon Stock 474I By SpouseAs of 2026-06-04 Open filing 4
Brautigam Sharon E DirectorCommon Stock 24,842D As of 2026-06-04 Open filing 4
DeBergalis Michelle M DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock8,220D As of 2026-03-20 Open filing 4
DeBergalis Michelle M DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock8,220D As of 2025-12-09 Open filing 4
DeBergalis Michelle M DirectorCommon Stock 4,511D As of 2025-07-18 Open filing 3
DeBergalis Michelle M DirectorCommon Stock 157I By IRAAs of 2026-03-20 Open filing 4
DeBergalis Michelle M DirectorCommon Stock 8,859D As of 2026-03-18 Open filing 4
Gilden Taylor M Officer: Chief Financial OfficerCommon Stock 19,375D As of 2025-07-18 Open filing 3
Gilden Taylor M Officer: CFO and TreasurerCommon Stock 372I By ESOPAs of 2026-03-20 Open filing 4
Gilden Taylor M Officer: CFO and TreasurerCommon Stock 2,522I By IRAAs of 2026-03-20 Open filing 4
Gilden Taylor M Officer: CFO and TreasurerCommon Stock 22,403D As of 2026-03-18 Open filing 4
LIDDELL KIM C Other: Dir., Pres. and CEO of BankCommon Stock 65,478D As of 2025-07-18 Open filing 3
LIDDELL KIM C Other: Dir., Pres. and CEO of BankCommon Stock 1,949I By ESOPAs of 2026-04-24 Open filing 4
LIDDELL KIM C Other: Dir., Pres. and CEO of BankCommon Stock 41,661I By IRAAs of 2026-04-24 Open filing 4
LIDDELL KIM C Other: Dir., Pres. and CEO of BankCommon Stock 10,000I By SpouseAs of 2026-04-24 Open filing 4
LIDDELL KIM C Other: Dir., Pres. and CEO of BankCommon Stock 70,367D As of 2026-04-23 Open filing 4
McGrath John P DirectorStock Option Derivative security · underlying Common Stock8,220D As of 2026-03-20 Open filing 4
McGrath John P DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock8,220D As of 2025-12-09 Open filing 4
McGrath John P DirectorCommon Stock 10,284D As of 2026-01-23 Open filing 4
McGrath John P DirectorCommon Stock 79,927I By IRAAs of 2026-03-20 Open filing 4
McGrath John P DirectorCommon Stock 10,873D As of 2026-03-18 Open filing 4
Mehltretter John L DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock7,468D As of 2026-03-20 Open filing 4
Mehltretter John L DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock5,237D As of 2025-12-09 Open filing 4
Mehltretter John L DirectorCommon Stock 18,933D As of 2026-01-23 Open filing 4
Mehltretter John L DirectorCommon Stock 20,000I By IRAAs of 2026-03-20 Open filing 4
Mehltretter John L DirectorCommon Stock 19,600D As of 2026-03-18 Open filing 4
POLLACK DENNIS DirectorCommon Stock 0D As of 2026-03-24 Open filing 3
Passafaro Ronald J DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock10,749D As of 2026-03-20 Open filing 4
Passafaro Ronald J DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock10,749D As of 2025-12-09 Open filing 4
Passafaro Ronald J DirectorCommon Stock 45,264D As of 2026-01-23 Open filing 4
Passafaro Ronald J DirectorCommon Stock 2,438I By IRAAs of 2026-03-20 Open filing 4
Passafaro Ronald J DirectorCommon Stock 45,837D As of 2026-03-18 Open filing 4
Sanvidge Kevin M. Director · Other: Chairman of the BoardOption (right to buy) Derivative security · underlying Common Stock2,570D As of 2026-09-09 Open filing 4
Sanvidge Kevin M. Director · Other: Chairman of the BoardStock Option (Right to Buy) Derivative security · underlying Common Stock2,570D As of 2026-03-20 Open filing 4
Sanvidge Kevin M. Director · Other: Chairman of the BoardOption (right to buy) Derivative security · underlying Common Stock0D As of 2026-09-08 Open filing 4
Sanvidge Kevin M. Director · Other: Chairman of the BoardCommon Stock 56,920D As of 2025-07-18 Open filing 3
Sanvidge Kevin M. Director · Other: Chairman of the BoardCommon Stock 3,150I As Custodian for GrandchildrenAs of 2026-09-09 Open filing 4
Sanvidge Kevin M. Director · Other: Chairman of the BoardCommon Stock 71,887D As of 2026-09-08 Open filing 4
Sanvidge Kevin M. Director · Other: Chairman of the BoardCommon Stock 3,150I As Custodian for GrandchildrenAs of 2025-12-10 Open filing 4/A
Segarra Ann M DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock10,749D As of 2026-03-20 Open filing 4
Segarra Ann M DirectorStock Option (Right to Buy) Derivative security · underlying Common Stock10,749D As of 2025-12-09 Open filing 4
Segarra Ann M DirectorCommon Stock 1,014D As of 2025-07-18 Open filing 3
Segarra Ann M DirectorCommon Stock 81,840I By IRAAs of 2026-03-20 Open filing 4
Segarra Ann M DirectorCommon Stock 6,692D As of 2026-03-18 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionStock Option (Right to Buy) Derivative security · underlying Common Stock23,132D As of 2026-04-24 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionOption (right to buy) Derivative security · underlying Common Stock0D As of 2026-08-21 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionCommon Stock 51,900D As of 2026-02-13 Open filing 5
Werdein Jeffrey M. Officer: EVP-Commercial DivisionCommon Stock 7,782I By ESOPAs of 2026-08-25 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionCommon Stock 20,000I By IRAAs of 2026-08-25 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionCommon Stock 1,056I By SonAs of 2026-04-24 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionCommon Stock 2,000I By SpouseAs of 2026-08-25 Open filing 4
Werdein Jeffrey M. Officer: EVP-Commercial DivisionCommon Stock 60,862D As of 2026-08-21 Open filing 4

Joint filers each report the same shares, so rows are not added together.

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–39 of 39

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
STILWELL VALUE LLC 773,675 SH14,049,938 dollarsUnchanged Prior quarter: 773,675Open filing 0001397076-26-000018 Filed 2026-11-16 Dispute this row
ALLIANCEBERNSTEIN L.P. Partly reported under another manager505,971 SH9,188,433 dollarsUnchanged Prior quarter: 505,971Open filing 0001109448-26-000342 Filed 2026-11-16 Dispute this row
Oppenheimer Close, LLC 184,248 SH3,345,944 dollarsHigher by 4,248 Prior quarter: 180,000Open filing 0001062993-26-005838 Filed 2026-11-09 Dispute this row
MANGROVE PARTNERS IM, LLC 163,134 SH2,962,513 dollarsHigher by 12,549 Prior quarter: 150,585Open filing 0001172661-26-005117 Filed 2026-11-16 Dispute this row
HBK Sorce Advisory LLC Partly reported under another manager85,113 SH1,594,166 dollarsLower by 60 Prior quarter: 85,173Open filing 0001379995-26-000006 Filed 2026-11-06 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 85,067 SH1,544,817 dollarsHigher by 57,625 Prior quarter: 27,442Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
GRAHAM CAPITAL WEALTH MANAGEMENT, LLC 83,831 SH1,522,373 dollarsHigher by 9,288 Prior quarter: 74,543Open filing 0001951757-26-001773 Filed 2026-10-26 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager67,741 SH1,230,177 dollarsHigher by 2,100 Prior quarter: 65,641Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Peapod Lane Capital LLC 66,381 SH1,205,486 dollarsLower by 3,658 Prior quarter: 70,039Open filing 0001941040-26-000768 Filed 2026-10-22 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager55,377 SH1,005,822 dollarsHigher by 28,648 Prior quarter: 26,729Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
DIMENSIONAL FUND ADVISORS LP Partly reported under another manager48,600 SH882,732 dollarsHigher by 667 Prior quarter: 47,933Open filing 0000354204-26-001096 Filed 2026-11-04 Dispute this row
Minerva Advisors LLC 44,259 SH803,743 dollarsUnchanged Prior quarter: 44,259Open filing 0001420506-26-002635 Filed 2026-11-13 Dispute this row
VANGUARD FIDUCIARY TRUST CO 35,294 SH640,939 dollarsHigher by 23,808 Prior quarter: 11,486Open filing 0000933478-26-000017 Filed 2026-11-13 Dispute this row
BlackRock, Inc. Partly reported under another manager34,949 SH634,674 dollarsHigher by 5,444 Prior quarter: 29,505Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Partly reported under another manager33,914 SH615,878 dollarsNot in the prior quarter’s filings read Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
COURIER CAPITAL LLC 25,702 SH466,748 dollarsHigher by 8 Prior quarter: 25,694Open filing 0001420506-26-002338 Filed 2026-10-19 Dispute this row
FIRST MANHATTAN CO. LLC. 25,075 SH455,362 dollarsUnchanged Prior quarter: 25,075Open filing 0000728083-26-000010 Filed 2026-11-16 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager23,868 SH428 dollarsLower by 6,089 Prior quarter: 29,957Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
Sandhill Capital Partners LLC 17,151 SH311,458 dollarsLower by 1,067 Prior quarter: 18,218Open filing 0001556245-26-000006 Filed 2026-11-12 Dispute this row
Round Hill Asset Management Partly reported under another manager15,715 SH285,384 dollarsUnchanged Prior quarter: 15,715Open filing 0001696438-26-000007 Filed 2026-11-13 Dispute this row
Cerity Partners LLC 15,335 SH278,484 dollarsUnchanged Prior quarter: 15,335Open filing 0001172661-26-005020 Filed 2026-11-13 Dispute this row
NORTHERN TRUST CORP Partly reported under another manager14,444 SH262,303 dollarsNot in the prior quarter’s filings read Open filing 0000073124-26-000067 Filed 2026-11-16 Dispute this row
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 13,677 SH246,733 dollarsNot in the prior quarter’s filings read Open filing 0001214659-26-012804 Filed 2026-10-13 Dispute this row
BRIDGEWAY CAPITAL MANAGEMENT, LLC 12,393 SH225,057 dollarsLower by 175 Prior quarter: 12,568Open filing 0001107261-26-000007 Filed 2026-11-16 Dispute this row
JANE STREET GROUP, LLC Partly reported under another manager11,629 SH211,182 dollarsNot in the prior quarter’s filings read Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
Empowered Funds, LLC Partly reported under another manager10,181 SH184,887 dollarsNot in the prior quarter’s filings read Open filing 0001592828-26-000008 Filed 2026-11-13 Dispute this row
ROYAL BANK OF CANADA Partly reported under another manager4,954 SH90,000 dollarsHigher by 696 Prior quarter: 4,258Open filing 0001140361-26-044123 Filed 2026-11-16 Dispute this row
Tower Research Capital LLC (TRC) Partly reported under another manager4,296 SH78,015 dollarsNot in the prior quarter’s filings read Open filing 0001533421-26-000010 Filed 2026-11-16 Dispute this row
BARCLAYS PLC Partly reported under another manager3,376 SH61,308 dollarsHigher by 3,367 Prior quarter: 9Open filing 0000312069-26-000241 Filed 2026-11-06 Dispute this row
Vanguard Global Advisers, LLC 2,915 SH52,936 dollarsNot in the prior quarter’s filings read Open filing 0001811242-26-000017 Filed 2026-11-13 Dispute this row
MORGAN STANLEY Partly reported under another manager2,485 SH45,127 dollarsLower by 27,648 Prior quarter: 30,133Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
Farther Finance Advisors, LLC 1,354 SH24,589 dollarsUnchanged Prior quarter: 1,354Open filing 0001992825-26-000006 Filed 2026-10-08 Dispute this row
OSAIC HOLDINGS, INC. Partly reported under another manager745 SH13,589 dollarsHigher by 1 Prior quarter: 744Open filing 0001677044-26-000011 Filed 2026-11-12 Dispute this row
UBS Group AG Partly reported under another manager719 SH13,057 dollarsLower by 4,189 Prior quarter: 4,908Open filing 0001610520-26-000121 Filed 2026-11-10 Dispute this row
Mirae Asset Global Investments Co., Ltd. 633 SH11,495 dollarsUnchanged Prior quarter: 633Open filing 0000905148-26-004586 Filed 2026-10-29 Dispute this row
WHITTIER TRUST CO 628 SH11,461 dollarsUnchanged Prior quarter: 628Open filing 0001999371-26-025126 Filed 2026-11-12 Dispute this row
Arax Advisory Partners Partly reported under another manager541 SH9,825 dollarsUnchanged Prior quarter: 541Open filing 0001586767-26-000009 Filed 2026-11-12 Dispute this row
ASSETMARK, INC 172 SH3,124 dollarsNot in the prior quarter’s filings read Open filing 0001344551-26-000010 Filed 2026-10-21 Dispute this row
Capital Advisors, Ltd. LLC 8 SH0 dollarsUnchanged Prior quarter: 8Open filing 0001597878-26-000005 Filed 2026-10-27 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • Marquette Asset Management, LLC 9,652 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text; they are read only when their rows add up to the totals the filer states.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Institutional ownership reported on Form 13F

13F filers report holding between 7.70% and 32.07% of shares outstanding.

Quarter ending 2026-09-30, against 7,718,506 shares on the cover dated 2026-11-05.

  • The lower figure counts positions a manager reports as its own with sole discretion. The upper figure counts every plain-share position and can count a share twice.
  • Neither includes holders that do not file Form 13F, or managers below the filing threshold.
Quarter-by-quarter 13F holders
QuarterManagers holdingShares, at leastShares, at mostFilings read
2026-09-30 39594,3872,475,5508,935
2026-06-30 32559,8862,288,4119,178
2026-03-31 30558,1522,233,0829,173
2025-12-31 30563,0542,174,0699,222
2025-09-30 33672,3482,185,6888,469
2025-06-30 21232,456493,4458,516
2025-03-31 20237,880489,1348,518
2024-12-31 21277,981511,0388,580

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read from their tags. Earlier schedules are free text: they are read only when every cover page states a share count and a percent, and the rest are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
AllianceBernstein L.P. Common Stock5.7448,959.0003/31/2026 Filed 2026-05-18SCHEDULE 13GOpen filing 0001109448-26-000145 Dispute this row
Stilwell Activist Fund, L.P. Common Stock, par value $0.01 per share9.9773,675.0003/17/2026 Filed 2026-03-18SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000293 Dispute this row
Stilwell Activist Investments, L.P. Common Stock, par value $0.01 per share9.9773,675.0003/17/2026 Filed 2026-03-18SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000293 Dispute this row
STILWELL PARTNERS L P Common Stock, par value $0.01 per share9.9773,675.0003/17/2026 Filed 2026-03-18SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000293 Dispute this row
Stilwell Value LLC Common Stock, par value $0.01 per share9.9773,675.0003/17/2026 Filed 2026-03-18SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000293 Dispute this row
Stilwell Joseph Common Stock, par value $0.01 per share9.9773,675.0003/17/2026 Filed 2026-03-18SCHEDULE 13D/AAmendment 3Open filing 0001193805-26-000293 Dispute this row
Stilwell Activist Fund, L.P. Common Stock, par value $0.01 per share9.9773,675.0002/17/2026 Filed 2026-02-18SCHEDULE 13D/AAmendment 2Open filing 0000921895-26-000497 Dispute this row
Stilwell Activist Investments, L.P. Common Stock, par value $0.01 per share9.9773,675.0002/17/2026 Filed 2026-02-18SCHEDULE 13D/AAmendment 2Open filing 0000921895-26-000497 Dispute this row
STILWELL PARTNERS L P Common Stock, par value $0.01 per share9.9773,675.0002/17/2026 Filed 2026-02-18SCHEDULE 13D/AAmendment 2Open filing 0000921895-26-000497 Dispute this row
Stilwell Value LLC Common Stock, par value $0.01 per share9.9773,675.0002/17/2026 Filed 2026-02-18SCHEDULE 13D/AAmendment 2Open filing 0000921895-26-000497 Dispute this row
Stilwell Joseph Common Stock, par value $0.01 per share9.9773,675.0002/17/2026 Filed 2026-02-18SCHEDULE 13D/AAmendment 2Open filing 0000921895-26-000497 Dispute this row
Stilwell Activist Fund, L.P. Common Stock, par value $0.01 per share9.9773,675.0010/06/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001193805-25-001408 Dispute this row
Stilwell Activist Investments, L.P. Common Stock, par value $0.01 per share9.9773,675.0010/06/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001193805-25-001408 Dispute this row
STILWELL PARTNERS L P Common Stock, par value $0.01 per share9.9773,675.0010/06/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001193805-25-001408 Dispute this row
Stilwell Value LLC Common Stock, par value $0.01 per share9.9773,675.0010/06/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001193805-25-001408 Dispute this row
Stilwell Joseph Common Stock, par value $0.01 per share9.9773,675.0010/06/2025 Filed 2025-10-06SCHEDULE 13D/AAmendment 1Open filing 0001193805-25-001408 Dispute this row
Employee Stock Ownership Plan Trust of Lake Shore Bancorp, Inc. Common Stock, par value $0.01 per share7.8607,45909/30/2025 Filed 2025-11-14SCHEDULE 13GOpen filing 0000943374-25-000473 Dispute this row
Stilwell Activist Fund, L.P. Common Stock, par value $0.01 per share9.4738,675.0007/23/2025 Filed 2025-07-30SCHEDULE 13DOpen filing 0000921895-25-002050 Dispute this row
Stilwell Activist Investments, L.P. Common Stock, par value $0.01 per share9.4738,675.0007/23/2025 Filed 2025-07-30SCHEDULE 13DOpen filing 0000921895-25-002050 Dispute this row
STILWELL PARTNERS L P Common Stock, par value $0.01 per share9.4738,675.0007/23/2025 Filed 2025-07-30SCHEDULE 13DOpen filing 0000921895-25-002050 Dispute this row
Stilwell Value LLC Common Stock, par value $0.01 per share9.4738,675.0007/23/2025 Filed 2025-07-30SCHEDULE 13DOpen filing 0000921895-25-002050 Dispute this row
STILWELL JOSEPH Common Stock, par value $0.01 per share9.4738,675.0007/23/2025 Filed 2025-07-30SCHEDULE 13DOpen filing 0000921895-25-002050 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

3,104,499 filings read, dated 1980-01-02 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015258,595
2016246,472
2017244,814
2018245,575
2019238,619
2020249,093
2021274,850
2022257,922
2023253,676
2024261,106
2025235,525
2026263,830

Filings made before the SEC required XML are listed, not extracted.

Back to LAKE SHORE BANCORP, INC.